IP Verse

Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator - EP3203840

PATENT ANALYSIS

Patent Details

Grant Date: Aug 5, 2020
Company: VERTEX PHARMACEUTICALS INCORPORATED
Oppositions

More patents of Vertex Pharmaceuticals Incorporated

Want to monitor this patent?

Feel free to send us a message here and we will get back to you